Distribution of p53 protein expression in gliosarcomas: an immunohistochemical study View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1993-01

AUTHORS

S. Albrecht, J. H. Connelly, J. M. Bruner

ABSTRACT

The wild-type p53 gene product is a nuclear phosphoprotein that suppresses cell and tumor growth. Mutations of the p53 gene are by now the most frequently recognized genetic alterations in human malignancies and occur in many types of carcinomas as well as in astrocytomas and sarcomas. Wild-type p53 protein has a short half-life, is present in very low quantities in normal cells and cannot be detected immunohistochemically. Mutant p53 proteins have longer half-lives and are usually present in immunohistologically detectable amounts. It is generally agreed that the presence of p53 immunostaining indicates the presence of an abnormal p53 protein and is strongly suggestive of a mutation in the p53 gene. In this study, we stained paraffin sections from eight samples of gliosarcomas from seven patients with an antibody to p53. All tumors contained p53-immunoreactive nuclei in both the glial and the sarcomatous component. In five tumors, a majority of nuclei was positive in the sarcomatous component while only a minority of nuclei was positive in the glial areas. In one tumor, the reverse was seen. In another tumor, approximately half the nuclei were positive in both components and in one tumor, only a minority of nuclei were positive in either component (this lesion was the recurrence of a tumor in which the majority of the sarcoma's nuclei had been positive). These data indicate that p53 mutations may play a role in the pathogenesis of gliosarcomas and suggest an origin of both the glial and sarcomatous components from a common progenitor. More... »

PAGES

222-226

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/bf00227772

DOI

http://dx.doi.org/10.1007/bf00227772

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1016219339

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/8382897


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glioblastoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glioma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunohistochemistry", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tumor Suppressor Protein p53", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Baylor College of Medicine, Houston, USA", 
          "id": "http://www.grid.ac/institutes/grid.39382.33", 
          "name": [
            "Department of Pathology, Baylor College of Medicine, Houston, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Albrecht", 
        "givenName": "S.", 
        "id": "sg:person.01022314100.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01022314100.48"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, (Box 85), Houston, USA", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Pathology, (Box 85), Houston, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Connelly", 
        "givenName": "J. H.", 
        "id": "sg:person.0733266344.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0733266344.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, (Box 85), Houston, USA", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Pathology, (Box 85), Houston, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bruner", 
        "givenName": "J. M.", 
        "id": "sg:person.013375073077.30", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013375073077.30"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf00294666", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036928902", 
          "https://doi.org/10.1007/bf00294666"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/342705a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041126170", 
          "https://doi.org/10.1038/342705a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00334506", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039043742", 
          "https://doi.org/10.1007/bf00334506"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00687802", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011945129", 
          "https://doi.org/10.1007/bf00687802"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/351453a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052393971", 
          "https://doi.org/10.1038/351453a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/355846a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024842732", 
          "https://doi.org/10.1038/355846a0"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1993-01", 
    "datePublishedReg": "1993-01-01", 
    "description": "The wild-type p53 gene product is a nuclear phosphoprotein that suppresses cell and tumor growth. Mutations of the p53 gene are by now the most frequently recognized genetic alterations in human malignancies and occur in many types of carcinomas as well as in astrocytomas and sarcomas. Wild-type p53 protein has a short half-life, is present in very low quantities in normal cells and cannot be detected immunohistochemically. Mutant p53 proteins have longer half-lives and are usually present in immunohistologically detectable amounts. It is generally agreed that the presence of p53 immunostaining indicates the presence of an abnormal p53 protein and is strongly suggestive of a mutation in the p53 gene. In this study, we stained paraffin sections from eight samples of gliosarcomas from seven patients with an antibody to p53. All tumors contained p53-immunoreactive nuclei in both the glial and the sarcomatous component. In five tumors, a majority of nuclei was positive in the sarcomatous component while only a minority of nuclei was positive in the glial areas. In one tumor, the reverse was seen. In another tumor, approximately half the nuclei were positive in both components and in one tumor, only a minority of nuclei were positive in either component (this lesion was the recurrence of a tumor in which the majority of the sarcoma's nuclei had been positive). These data indicate that p53 mutations may play a role in the pathogenesis of gliosarcomas and suggest an origin of both the glial and sarcomatous components from a common progenitor.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/bf00227772", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1019073", 
        "issn": [
          "0001-6322", 
          "1432-0533"
        ], 
        "name": "Acta Neuropathologica", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "85"
      }
    ], 
    "keywords": [
      "sarcomatous component", 
      "wild-type p53 gene product", 
      "p53 protein", 
      "types of carcinoma", 
      "p53 gene", 
      "p53 protein expression", 
      "p53 gene product", 
      "abnormal p53 protein", 
      "immunohistochemical study", 
      "p53 immunostaining", 
      "glial areas", 
      "tumor growth", 
      "mutant p53 protein", 
      "tumors", 
      "human malignancies", 
      "p53 mutations", 
      "wild-type p53 protein", 
      "paraffin sections", 
      "gliosarcoma", 
      "protein expression", 
      "genetic alterations", 
      "normal cells", 
      "detectable amounts", 
      "common progenitor", 
      "mutations", 
      "cells", 
      "sarcoma", 
      "patients", 
      "malignancy", 
      "carcinoma", 
      "pathogenesis", 
      "astrocytomas", 
      "glial", 
      "immunostaining", 
      "nucleus", 
      "antibodies", 
      "protein", 
      "minority", 
      "minority of nuclei", 
      "gene products", 
      "majority of nuclei", 
      "study", 
      "alterations", 
      "p53", 
      "genes", 
      "nuclear phosphoprotein", 
      "presence", 
      "majority", 
      "expression", 
      "progenitors", 
      "low quantities", 
      "role", 
      "reverse", 
      "components", 
      "phosphoprotein", 
      "data", 
      "samples", 
      "types", 
      "area", 
      "origin", 
      "sections", 
      "growth", 
      "amount", 
      "products", 
      "distribution", 
      "quantity", 
      "samples of gliosarcomas", 
      "p53-immunoreactive nuclei", 
      "pathogenesis of gliosarcomas"
    ], 
    "name": "Distribution of p53 protein expression in gliosarcomas: an immunohistochemical study", 
    "pagination": "222-226", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1016219339"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/bf00227772"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "8382897"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/bf00227772", 
      "https://app.dimensions.ai/details/publication/pub.1016219339"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:05", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_227.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/bf00227772"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf00227772'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf00227772'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf00227772'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf00227772'


 

This table displays all metadata directly associated to this object as RDF triples.

212 TRIPLES      22 PREDICATES      112 URIs      98 LITERALS      17 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/bf00227772 schema:about N07a4a81bc72c4cb39df3fbfedcd960f6
2 N3938656757774223b99927cd914ba721
3 N5739c6bdd72a4c3badf2f93fcd1e146e
4 N64e02fd76ed74710a71f2b49f885dc8f
5 N7c37e002a9cb4b01a14186f2a8cdf66e
6 N888a726758ec4a309067200c4e7add4b
7 Na2db5fa80fb84c2ebd8fc9492c39b40d
8 Naf43eaad4ddd48469e823ab42b170654
9 Nd716ff23e3af4234bfdb4eea18a347d9
10 Nda22191db96f4c3caec7239e0ea2562d
11 anzsrc-for:11
12 anzsrc-for:1112
13 schema:author N033ba94c18454a4b81229d779fd899a0
14 schema:citation sg:pub.10.1007/bf00294666
15 sg:pub.10.1007/bf00334506
16 sg:pub.10.1007/bf00687802
17 sg:pub.10.1038/342705a0
18 sg:pub.10.1038/351453a0
19 sg:pub.10.1038/355846a0
20 schema:datePublished 1993-01
21 schema:datePublishedReg 1993-01-01
22 schema:description The wild-type p53 gene product is a nuclear phosphoprotein that suppresses cell and tumor growth. Mutations of the p53 gene are by now the most frequently recognized genetic alterations in human malignancies and occur in many types of carcinomas as well as in astrocytomas and sarcomas. Wild-type p53 protein has a short half-life, is present in very low quantities in normal cells and cannot be detected immunohistochemically. Mutant p53 proteins have longer half-lives and are usually present in immunohistologically detectable amounts. It is generally agreed that the presence of p53 immunostaining indicates the presence of an abnormal p53 protein and is strongly suggestive of a mutation in the p53 gene. In this study, we stained paraffin sections from eight samples of gliosarcomas from seven patients with an antibody to p53. All tumors contained p53-immunoreactive nuclei in both the glial and the sarcomatous component. In five tumors, a majority of nuclei was positive in the sarcomatous component while only a minority of nuclei was positive in the glial areas. In one tumor, the reverse was seen. In another tumor, approximately half the nuclei were positive in both components and in one tumor, only a minority of nuclei were positive in either component (this lesion was the recurrence of a tumor in which the majority of the sarcoma's nuclei had been positive). These data indicate that p53 mutations may play a role in the pathogenesis of gliosarcomas and suggest an origin of both the glial and sarcomatous components from a common progenitor.
23 schema:genre article
24 schema:inLanguage en
25 schema:isAccessibleForFree false
26 schema:isPartOf N2ef2b9ee26fd4c86b2f1ad443d000907
27 Nf967462453e34cdeb42ce1a9c3edfb98
28 sg:journal.1019073
29 schema:keywords abnormal p53 protein
30 alterations
31 amount
32 antibodies
33 area
34 astrocytomas
35 carcinoma
36 cells
37 common progenitor
38 components
39 data
40 detectable amounts
41 distribution
42 expression
43 gene products
44 genes
45 genetic alterations
46 glial
47 glial areas
48 gliosarcoma
49 growth
50 human malignancies
51 immunohistochemical study
52 immunostaining
53 low quantities
54 majority
55 majority of nuclei
56 malignancy
57 minority
58 minority of nuclei
59 mutant p53 protein
60 mutations
61 normal cells
62 nuclear phosphoprotein
63 nucleus
64 origin
65 p53
66 p53 gene
67 p53 gene product
68 p53 immunostaining
69 p53 mutations
70 p53 protein
71 p53 protein expression
72 p53-immunoreactive nuclei
73 paraffin sections
74 pathogenesis
75 pathogenesis of gliosarcomas
76 patients
77 phosphoprotein
78 presence
79 products
80 progenitors
81 protein
82 protein expression
83 quantity
84 reverse
85 role
86 samples
87 samples of gliosarcomas
88 sarcoma
89 sarcomatous component
90 sections
91 study
92 tumor growth
93 tumors
94 types
95 types of carcinoma
96 wild-type p53 gene product
97 wild-type p53 protein
98 schema:name Distribution of p53 protein expression in gliosarcomas: an immunohistochemical study
99 schema:pagination 222-226
100 schema:productId N19aee6fd22ad4a0dad3cf7f6008131f1
101 Naa433d60264947a38937370a2cb98820
102 Nea8febf2c8774ba6a38f9e2377cb0f4e
103 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016219339
104 https://doi.org/10.1007/bf00227772
105 schema:sdDatePublished 2022-01-01T18:05
106 schema:sdLicense https://scigraph.springernature.com/explorer/license/
107 schema:sdPublisher Nc55899843dcf4cc3a5dcf51b309eb6cd
108 schema:url https://doi.org/10.1007/bf00227772
109 sgo:license sg:explorer/license/
110 sgo:sdDataset articles
111 rdf:type schema:ScholarlyArticle
112 N033ba94c18454a4b81229d779fd899a0 rdf:first sg:person.01022314100.48
113 rdf:rest N8a847f8e327e429892bb00a09e1bc39d
114 N07a4a81bc72c4cb39df3fbfedcd960f6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Glioblastoma
116 rdf:type schema:DefinedTerm
117 N19aee6fd22ad4a0dad3cf7f6008131f1 schema:name pubmed_id
118 schema:value 8382897
119 rdf:type schema:PropertyValue
120 N2ef2b9ee26fd4c86b2f1ad443d000907 schema:volumeNumber 85
121 rdf:type schema:PublicationVolume
122 N3938656757774223b99927cd914ba721 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Immunohistochemistry
124 rdf:type schema:DefinedTerm
125 N484863177e9941bfb569920351d4e18d rdf:first sg:person.013375073077.30
126 rdf:rest rdf:nil
127 N5739c6bdd72a4c3badf2f93fcd1e146e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Tumor Suppressor Protein p53
129 rdf:type schema:DefinedTerm
130 N64e02fd76ed74710a71f2b49f885dc8f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Aged
132 rdf:type schema:DefinedTerm
133 N7c37e002a9cb4b01a14186f2a8cdf66e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Middle Aged
135 rdf:type schema:DefinedTerm
136 N888a726758ec4a309067200c4e7add4b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Female
138 rdf:type schema:DefinedTerm
139 N8a847f8e327e429892bb00a09e1bc39d rdf:first sg:person.0733266344.35
140 rdf:rest N484863177e9941bfb569920351d4e18d
141 Na2db5fa80fb84c2ebd8fc9492c39b40d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Glioma
143 rdf:type schema:DefinedTerm
144 Naa433d60264947a38937370a2cb98820 schema:name doi
145 schema:value 10.1007/bf00227772
146 rdf:type schema:PropertyValue
147 Naf43eaad4ddd48469e823ab42b170654 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Humans
149 rdf:type schema:DefinedTerm
150 Nc55899843dcf4cc3a5dcf51b309eb6cd schema:name Springer Nature - SN SciGraph project
151 rdf:type schema:Organization
152 Nd716ff23e3af4234bfdb4eea18a347d9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Adult
154 rdf:type schema:DefinedTerm
155 Nda22191db96f4c3caec7239e0ea2562d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Male
157 rdf:type schema:DefinedTerm
158 Nea8febf2c8774ba6a38f9e2377cb0f4e schema:name dimensions_id
159 schema:value pub.1016219339
160 rdf:type schema:PropertyValue
161 Nf967462453e34cdeb42ce1a9c3edfb98 schema:issueNumber 2
162 rdf:type schema:PublicationIssue
163 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
164 schema:name Medical and Health Sciences
165 rdf:type schema:DefinedTerm
166 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
167 schema:name Oncology and Carcinogenesis
168 rdf:type schema:DefinedTerm
169 sg:journal.1019073 schema:issn 0001-6322
170 1432-0533
171 schema:name Acta Neuropathologica
172 schema:publisher Springer Nature
173 rdf:type schema:Periodical
174 sg:person.01022314100.48 schema:affiliation grid-institutes:grid.39382.33
175 schema:familyName Albrecht
176 schema:givenName S.
177 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01022314100.48
178 rdf:type schema:Person
179 sg:person.013375073077.30 schema:affiliation grid-institutes:None
180 schema:familyName Bruner
181 schema:givenName J. M.
182 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013375073077.30
183 rdf:type schema:Person
184 sg:person.0733266344.35 schema:affiliation grid-institutes:None
185 schema:familyName Connelly
186 schema:givenName J. H.
187 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0733266344.35
188 rdf:type schema:Person
189 sg:pub.10.1007/bf00294666 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036928902
190 https://doi.org/10.1007/bf00294666
191 rdf:type schema:CreativeWork
192 sg:pub.10.1007/bf00334506 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039043742
193 https://doi.org/10.1007/bf00334506
194 rdf:type schema:CreativeWork
195 sg:pub.10.1007/bf00687802 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011945129
196 https://doi.org/10.1007/bf00687802
197 rdf:type schema:CreativeWork
198 sg:pub.10.1038/342705a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041126170
199 https://doi.org/10.1038/342705a0
200 rdf:type schema:CreativeWork
201 sg:pub.10.1038/351453a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052393971
202 https://doi.org/10.1038/351453a0
203 rdf:type schema:CreativeWork
204 sg:pub.10.1038/355846a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024842732
205 https://doi.org/10.1038/355846a0
206 rdf:type schema:CreativeWork
207 grid-institutes:None schema:alternateName Department of Pathology, (Box 85), Houston, USA
208 schema:name Department of Pathology, (Box 85), Houston, USA
209 rdf:type schema:Organization
210 grid-institutes:grid.39382.33 schema:alternateName Department of Pathology, Baylor College of Medicine, Houston, USA
211 schema:name Department of Pathology, Baylor College of Medicine, Houston, USA
212 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...